UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

被引:96
作者
Ardley, HC [1 ]
Scott, GB [1 ]
Rose, SA [1 ]
Tan, NGS [1 ]
Robinson, PA [1 ]
机构
[1] Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England
关键词
de-ubiquitylating enzyme; inclusion bodies; neurodegeneration; Parkinson's disease; ubiquitin;
D O I
10.1111/j.1471-4159.2004.02485.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aggresomes are associated with many neurodegenerative disorders, including Parkinson's disease, and polyglutamine disorders such as Huntington's disease. These inclusions commonly contain ubiquitylated proteins. The stage at which these proteins are ubiquitylated remains unclear. A malfunction of the ubiquitin/proteasome system (UPS) may be associated with their formation. Conversely, it may reflect an unsuccessful attempt by the cell to remove them. Previously, we demonstrated that overexpression of Parkin, a ubiquitin-protein ligase associated with autosomal recessive juvenile Parkinsonism, generates aggresome-like inclusions in UPS compromised cells. Mutations in the de-ubiquitylating enzyme, UCH-L1, cause a rare form of Parkinsonism. We now demonstrate that overexpression of UCH-L1 also forms ribbon-like aggresomes in response to proteasomal inhibition. Disease-associated mutations, which affect enzymatic activities, significantly increased the number of inclusions. UCH-L1 aggresomes co-localized with ubiquitylated proteins, HSP70, gamma-tubulin and, to a lesser extent, the 20S proteasome and the chaperone BiP. Similar to Parkin inclusions, we found UCH-L1 aggresomes to be surrounded by a tubulin rather than a vimentin cage-like structure. Furthermore, UCH-L1 aggregates with Parkin and alpha-synuclein in some, but not all inclusions, suggesting the heterogeneous nature of these inclusion bodies. This study provides additional evidence that aggregation-prone proteins are likely to recruit UPS components in an attempt to clear proteins from failing proteasomes. Furthermore, UCH-L1 accumulation is likely to play a pathological role in inclusion formation in Parkinson's disease.
引用
收藏
页码:379 / 391
页数:13
相关论文
共 73 条
  • [51] PATHOLOGY AND BIOLOGY OF THE LEWY BODY
    POLLANEN, MS
    DICKSON, DW
    BERGERON, C
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03) : 183 - 191
  • [52] Proteasomal inhibition leads to formation of ubiquitin/α-synuclein-immunoreactive inclusions in PC12 cells
    Rideout, HJ
    Larsen, KE
    Sulzer, D
    Stefanis, L
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 78 (04) : 899 - 908
  • [53] Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
    Saudou, F
    Finkbeiner, S
    Devys, D
    Greenberg, ME
    [J]. CELL, 1998, 95 (01) : 55 - 66
  • [54] Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies
    Schlossmacher, MG
    Frosch, MP
    Gai, WP
    Medina, M
    Sharma, N
    Forno, L
    Ochiishi, T
    Shimura, H
    Sharon, R
    Hattori, N
    Langston, JW
    Mizuno, Y
    Hyman, BT
    Selkoe, DJ
    Kosik, KS
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (05) : 1655 - 1667
  • [55] ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum
    Serwold, T
    Gonzalez, F
    Kim, J
    Jacob, R
    Shastri, N
    [J]. NATURE, 2002, 419 (6906) : 480 - 483
  • [56] Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases
    Sherman, MY
    Goldberg, AL
    [J]. NEURON, 2001, 29 (01) : 15 - 32
  • [57] Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
    Shimura, H
    Hattori, N
    Kubo, S
    Mizuno, Y
    Asakawa, S
    Minoshima, S
    Shimizu, N
    Iwai, K
    Chiba, T
    Tanaka, K
    Suzuki, T
    [J]. NATURE GENETICS, 2000, 25 (03) : 302 - 305
  • [58] Ubiquitination of a new form of α-synuclein by parkin from human brain:: Implications for Parkinson's disease
    Shimura, H
    Schlossmacher, MC
    Hattori, N
    Frosch, MP
    Trockenbacher, A
    Schneider, R
    Mizuno, Y
    Kosik, KS
    Selkoe, DJ
    [J]. SCIENCE, 2001, 293 (5528) : 263 - 269
  • [59] Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO
  • [60] 2-Z